RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV

Sponsor
Eskisehir Osmangazi University
Study ID
NCT07346963
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acute Bronchiolitis Due to Respiratory Syncytial Virus
  • Pneumonia
  • Respiratory Syncytial Virus Infection
  • Upper Respiratory Tract Infection

Eligibility Criteria

Sex
ALL
Age
28 Days - 5 Years
Healthy Volunteers
Not accepted

Study Details

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in infants and young children and contributes substantially to pediatric emergency department (ED) visits and hospitalizations. In Türkiye, nationally representative prospective data describing the epidemiology, clinical spectrum, and resource utilization of RSV-positive children presenting to pediatric EDs remain limited. This multicenter prospective observational study aims to characterize demographic and clinical features of RSV-positive children under 5 years of age presenting to participating pediatric EDs across two consecutive RSV seasons, and to quantify key healthcare utilization outcomes, including ED observation duration, hospitalization, and intensive care unit (ICU) admission.

Key Dates

First listed
Jan 16, 2026
Start date
Jan 1, 2026
Status verified
Dec 2025
Primary completion
Jan 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
4,000 participants (estimated)

Primary Outcome Measure

Hospitalization rate [ Time Frame: Index ED visit (from ED presentation/triage to ED disposition decision and departure from the ED for inpatient admission or discharge), up to 24 hours. ]

Central Contacts

Related Studies